| Literature DB >> 35136373 |
Mehrab Pourmadadi1, Fatemeh Yazdian2, Sara Hojjati2, Kianoush Khosravi-Darani3.
Abstract
Having an insight into graphene and graphene derivatives such as graphene oxide, reduced graphene oxide and graphene quantum dots is necessary since it can help scientists to detect possible properties and features that could be useful when using these carbon materials in preparation of a nanocomposites. In recent years, graphene and its derivatives have attracted a lot of attention and been extensively applied in biosensors due to fascinating properties, such as large surface area, optical and magnetic properties, and high elasticity for the detection of microorganisms as they can be modified with some other materials such as macromolecules, oxide metals and metals to improve the electrochemical behaviour of the biosensor. In this review paper, biosensor design strategies based on graphene and its derivatives (graphene-based nanocomposites in biosensors) are described. Then their application for the detection of microorganisms including prions, viroids, viral and bacterial cells as well as fungi, protozoa, microbial toxins and even microbial sources of antibiotics is reviewed.Entities:
Keywords: graphene; graphene oxide; graphene quantum dots; microorganism detection; nanobiosensors; reduced graphene oxide
Year: 2021 PMID: 35136373 PMCID: PMC8753800 DOI: 10.17113/ftb.59.04.21.7223
Source DB: PubMed Journal: Food Technol Biotechnol ISSN: 1330-9862 Impact factor: 3.918
Graphene and its derivative materials used as biosensors for detection of prions, viroids, viruses, bacterial cells, fungi, protozoa, microbial toxins and microbially derived antibiotics
| Graphene and its derivatives | Materials in composition with graphene | Biorecognition element | Detected material | Detection limit | Linear range | Type of biosensor | Ref. | |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| GO | - | FITC-PrP(95–110) | amyloid-β oligomers | - | 0.01–2 µM | 60 | fluorescent | ( |
| GO | - | ssDNA | sensitive prion disease-associated isoform | 4.2410−5 nM | 0.001–1 ng/mL | 40 | surface plasmon resonance | ( |
|
| ||||||||
| Graphene | zinc oxide | ssDNA | coconut cadang-cadang viroid | 4.310–12 M | 10–11–10−6 M | 60 | electrochemical | ( |
| GQD | SiO2 nanoparticles and NaYF4:Yb,Er | ssDNA | miRNA HIV1-miR-Tar-5p | 10 fM | above 10-6 M | - | fluorescent | ( |
|
| ||||||||
| GO | 1-pyrenebutyric acid | antibody | rotavirus | 10 PFU | 10–105 PFU/mL | - | electrochemical | ( |
| Graphene | poly(3-thiophene boronic acid) and gold nanoparticles | antibody | avian leukosis | 210 tissue culture infective dose per 50 mL | 527–3162 infective dose per 50 mL | - | electrochemical | ( |
| Graphene | silver nanoparticles and chitosan | H7-polyclonal antibody | avian influenza virus H7 | 1.6 pg/mL | 1.610-3–16 ng/mL | 30 | electrochemical | ( |
| RGO | - | antibody | rotavirus | 102 PFU | 10–105 PFU/mL | - | field-effect transistor | ( |
| GO | - | - | enteric EV71 and H9N2 | - | - | 30 | RT-PCR | ( |
| GO | - | ssDNA | Ebola virus | 1.4 pM | 30 fM–3 nM | - | fluorescent | ( |
| RGO | - | antibody | influenza | 102 PFU | 10–106 PFU/mL | 15 | electrochemical | ( |
| RGO | MOS2 | ssDNA | human papillomavirus | 0.1 ng/mL | 0.2–2 ng/mL | - | electrochemical | ( |
|
| ||||||||
| GNPs | SiO2 substrates- graphene (GNPs and Mg) | anti- | 10–100 cell/mL | 102–106 (GNPs) and 10–107 cell/mL (GNPs+Mg) | 30 | electrical | ( | |
| Graphene | carboxyl | a virulent phage called PaP1 |
| 56 CFU/mL | 1.4·102−106 CFU/mL | 30 | electrochemiluminescent | ( |
| GO | - | anti- |
| 10–100 μg/mL | - | - | infrared spectroscopy | ( |
| QDs and GO | - | complementary to the | 4 nM | - | 20 | fluorescence resonance energy transfer | ( | |
| GQD | nitrogen-doped GQD | 8 CFU/mL | 10–107 CFU/mL | 120 | ECL | ( | ||
| RGO | indole-5-carboxylic acid | ssDNA |
| target DNA down to 310-11 M | 10-6–10-10 M | electrochemical | ( | |
| RGO | RGO-Cu(II) | monoclonal antibodies |
| 4.4 CFU/mL | 10–108 CFU/mL | electrochemical | ( | |
|
| ||||||||
| Graphene | gold nanoparticles and cysteamine | antibody |
| 309 ng/mL | 0.2–4 mg/mL | 90 | electrochemical | ( |
|
| ||||||||
| RGO | gold nanoparticles | ssDNA | endotoxin | 1 fg/mL | 0.1–0.9 pg/mL | 30 | electrochemical | ( |
| Graphene | - | antibody | microcystin-LR | 0.05 μg/L | 0.05–20 μg/L | - | electrochemical | ( |
|
| ||||||||
| Graphene | silver nanoparticles/sulfonate | - | chloramphenicol | 0.01 mM | 0.02–20.0 μM | - | electrochemical | ( |
GO=graphene oxide, GQD=graphene quantum dots, RGO=reduced graphene oxide, GNPs=graphene nanoparticles, RT-PCR=reverse transcription polymerase chain reaction, ECL=electrochemiluminescence